THE ENDEAVOUR PRACTICE
20 CLEVELAND SQUARE, CLEVELAND CENTRE, MIDDLESBROUGH
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 25 | 36 | 69.4% | |
| HF 4 | 2011 | 32 | 39 | 82.1% | |
| HF 4 | 2012 | 32 | 35 | 91.4% | |
| HF 4 | 2013 | 29 | 30 | 96.7% | |
| HF004 | 2014 | 28 | 30 | 93.3% | |
| HF004 | 2015 | 28 | 28 | 100.0% | |
| HF004 | 2016 | 30 | 32 | 93.8% | |
| HF004 | 2017 | 27 | 32 | 84.4% | |
| HF004 | 2018 | 26 | 29 | 89.7% | |
| HF004 | 2019 | 28 | 32 | 87.5% | |
| HF004 | 2020 | 29 | 29 | 100.0% | |
| HF006 | 2021 | 31 | 31 | 100.0% | |
| HF006 | 2022 | 31 | 31 | 100.0% | |
| HF006 | 2023 | 30 | 31 | 96.8% |
